Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 706 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$18.86M
Operating Margin
-835.53%
TTM Avg
-421.37%
3Y Avg
-210.69%
5Y Avg
-1650.61%
Market Cap
$19.66M
Operating Margin
-18.53%
TTM Avg
-19.68%
3Y Avg
-50.34%
5Y Avg
-39.44%
Market Cap
$19.86M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$19.96M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$20.92M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$17.48M
Operating Margin
-24.65%
TTM Avg
-26.95%
3Y Avg
-27.41%
5Y Avg
-18.80%
Market Cap
$17.15M
Operating Margin
-524.69%
TTM Avg
-267.50%
3Y Avg
-582.47%
5Y Avg
-385.07%
Market Cap
$17.01M
Operating Margin
0.00%
TTM Avg
-84.34%
3Y Avg
-293.08%
5Y Avg
-1756.66%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NextCure, Inc. (NXTC) | $19.14M | 0.00% | 0.00% | 0.00% | 0.00% |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.86M | -835.53% | -421.37% | -210.69% | -1650.61% |
| P3 Health Partners Inc. (PIII)vs › | $19.66M | -18.53% | -19.68% | -50.34% | -39.44% |
| Actuate Therapeutics Inc (ACTU)vs › | $19.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.96M | 0.00% | 0.00% | 0.00% | 0.00% |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cosmos Health Inc. (COSM)vs › | $17.48M | -24.65% | -26.95% | -27.41% | -18.80% |
| Lipocine Inc. (LPCN)vs › | $17.15M | -524.69% | -267.50% | -582.47% | -385.07% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | 0.00% | -84.34% | -293.08% | -1756.66% |
| Modular Medical, Inc. (MODD)vs › | $21.68M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 36.70% |
| 2019-12-31 | -599.00% |
| 2019-09-30 | -612.89% |
| 2019-06-30 | -638.73% |
| 2019-03-31 | -502.21% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
